Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from brazilian amerindians

AIDS Research and Human Retroviruses

Volumn 29, Issue 7, 2013, Pages 1010-1018

  Magri, Mariana Cavalheiro ^a   De MacEdo Brigido, Luis Fernando ^b   Morimoto, Helena Kaminami ^c   Caterino De Araujo, Adele ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

^d Secretaria de Estado da Saude de Sao Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TAX PROTEIN; VIRUS ENVELOPE PROTEIN;

AMERICAN INDIAN; ARTICLE; BRAZIL; EVOLUTIONARY RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 2A; INTRAVENOUS DRUG ABUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; VIRUS TRANSMISSION;

ADULT; AMINO ACID SEQUENCE; BRAZIL; DNA, VIRAL; FEMALE; GENE PRODUCTS, TAX; GENES, ENV; GENES, PX; HIV INFECTIONS; HIV-1; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INDIANS, SOUTH AMERICAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID; TERMINAL REPEAT SEQUENCES;

EID: 84879139974     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0014     Document Type: Article

References (39)

1. Murphy EL, Mahieux R, De Thé G, et al.: Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug user: An age-cohort effect for HTLV-II RFLP type a. Virology 1998;242:425-434.
2. Zella D, Mori L, Ferrante P, Casoli C, Magnani G, Achilli G, Cattaneo E, Lori F, and Bertazzoni U: HTLV-II infection in Italian drug users. Lancet 1990;335:575-576.
3. Taylor GP: The human T cell lymphotropic viruses. In: Principles and Practice of Clinical Virology, 5th ed. (Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD, eds.). John Wiley & Sons Ltd, Piscataway, NJ, 2004, pp. 759-777.
4. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, and Interdisciplinary HTLV Research Group: Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban areas in Brazil. Cadern Saúde Pú bl (Rio de J) 2005;21:926-931.
5. Gabbai AA, Bordini JO, Vieira-Filho JPB, et al.: Selectivity of human T lymphotropic vírus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg 1993;49:664-671.
6. Etzel A, Shibata GY, Rozman M, Jorge MLSG, Damas CD, and Segurado AAC: HTLV-1 and HTLV-2 infections in HIV infected individuals from Santos, Brazil: Seroprevalence and risk factors. J Acquir Immune Defic Syndr 2001;26:185-190.
7. Ishak R, Vallinoto ACR, Azevedo VN, and Ishak MQ: Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil. Cad Saúde púb (Rio de J) 2003;19:901-914.
8. Menna-Barreto M, Bender AL, Bonatto SL, et al.: Human T cell lymphotropic virus type II in Guaraní Indians, Southern Brazil. Cad Saúde Púb (Rio de J) 2005;21:1947-1951.
9. Morimoto HK, Caterino-de-Araujo A, Morimoto AA, et al.: Seroprevalence and risk factors for human T-cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus (HIV)-infected patients attending AIDS Referral Center Health Units in Londrina and other communities in Paraná, Brazil. AIDS Res Hum Retroviruses 2005;21:256-262.
10. Oliveira EH, Oliveira-Filho AB, Souza LA, et al.: Human Tcell lymphotropic virus in patients infected with HIV-1: Molecular epidemiology and risk factors for transmission in Piauí, North-eastern Brazil. Curr HIV Res 2012;10:700-707.
11. Lemey P, Pybus OG, Van Dooren S, and Vandamme AM: A Bayesian statistical analysis of human T-cell lymphotropic virus evolutionary rates. Infect Genet Evol 2005;5:291-298.
12. Bangham CRM and Osame M: Cellular immune response to HTLV-1. Oncogene 2005;24:6035-6046.
13. Eiraku N, Novoa P, Ferreira MC, et al.: Identification and characterization of new and distinct molecular subtype of human T-cell lymphotropic vírus type 2. J Virol 1996;70:1481-1492.
14. Feuer G and Green PL: Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005;24:5996-6004.
15. Covas DM and Kashima S: Complete nucleotide sequences of the genomes of two Brazilian specimens of human T lymphotropic virus type 2 (HTLV-2). AIDS Res Hum Retroviruses 2003;19:689-697.
16. Ishak R, Harrington WJ, Azevedo VN, et al.: Identification of human T-cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-821.
17. Vandamme AM, Salemi M, Van Brussel M, et al.: African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol 1998;72:4327-4340.
18. Slattery JP, Franchini G, and Gessain A: Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 1999;9:525-540.
19. Alcantara LCJ, Shindo N, Van Doren S, et al.: Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs. AIDS Res Hum Retroviruses 2003;19:519-523.
20. Renner JDP, Laurino JP, Menna-Barreto M, and Schmitt VM: Molecular evidence of HTLV-II subtype B among an urban population living in South Brazil. AIDS Res Hum Retroviruses 2006;22:301-306.
21. Novoa P, Penalva de Oliveira AC, Posada-Vergara MP, Duarte AJS, and Casseb J: Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: Evidence of multiple subtypes circulation. J Med Virol 2007;79:182-187.
22. Magri MC, Morimoto HK, Brígido LFM, Rodrigues R, and Caterino-de-Araujo A: Long terminal repeat sequence analysis of HTLV-2 molecular variants identified in Southern Brazil. AIDS Res Hum Retroviruses 2010;26:1327-1331.
23. Egan JF, O'Leary B, Lewis MJ, et al.: High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses 1999;15:699-705.
24. Shindo N, Alcantara LC, Van Dooren S, et al.: Human retroviruses (HIV and HTLV) in Brazilian Indians: Seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res Hum Retroviruses 2002;18:71-77.
25. Lee H, Idler KB, Swanson P, et al.: Complete nucleotide sequence of HTLV-II isolate NRA: Comparison of envelope sequence variation of HTLV II isolates from U.S. blood donors and U.S. and Italian IV drug users. Virology 1993;196:57-69.
26. Salemi M, Vandamme AM, Gradozzi C, et al.: Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J Mol Evol 1998;46:602-611.
27. Lewis MJ, Sheehy N, Salemi M, VanDamme AM, and Hall WW: Comparison of CREB-and NK-B-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) Tax proteins. Virology 2002;295:182-189.
28. Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, and Vandamme A: Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA 1999;96:13253-13258.
29. Olah I, Fukumori LMI, Smid J, et al.: Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV Western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals. J Med Virol 2010;82: 837-842.
30. Wattel E, Vartanian JP, Pannetier C, and Wain-Hobson S: Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995;69:2863-2868.
31. Lemey P, Kosakovsky Pond SL, Drummond AJ, et al.: Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 2007;3(2):e29.
32. Hahn BH, Shaw GM, Taylor ME, et al.: Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 1986;232:1548-1553.
33. Biggar RJ, Taylor ME, Neel JV, et al.: Genetic variants or human T lymphotropic virus type II in American Indian groups. Virology 1996;216:165-173.
34. Switzer WM, Black FL, Pieniazek D, Biggar RJ, Lal RB, and Heneine W: Endemicity and phylogeny of the human T cell lymphotropic vírus type II subtype A from the Kayapo Indians of Brazil: Evidence for limited regional dissemination. AIDS Res Human Retroviruses 1996;12:635-640.
35. Mauclère P, Afonso PV, Meertens L, et al.: HTLV-2B strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola pygmies. J Infect Dis 2011; 203:1316-1323.
36. Suzuki Y and Gojobori T: The origin and evolution of the human T-cell lymphotropic virus type I and II. Virus Genes 1998;16:69-84.
37. Salemi M, Vandamme AM, Desmyter J, Casoli C, and Bertazzoni U: The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy. Gene 1999;234:11-21.
38. Abad M, Dronda F, Dominguez E, Moreno S, and Vallejo A: HTLV-2b among HIV type 1-coinfected injecting drug users in Spain. AIDS Res Hum Retroviruses 2011;27:579-583.
39. Salemi M, Cattaneo E, Casoli C, and Bertazzoni, U: Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr 1995;8:516-520. deDesenvolvimento Científico e Tecnológico (MCT/CNPq) Nível Superior